Baxter International Inc up sharply

Baxter International Inc closed up sharply Friday, rallying (U.S.)$0.76 or 1.72% to (U.S.)$44.84. Over the last five days, shares have gained 1.89% and 17.54% year to date. Shares have outperformed the S&P 500 by 11.60% during the last year.

Key company metrics

Open(U.S.) $44.21

Previous close(U.S.) $44.08

High(U.S.) $44.87

Low(U.S.) $44.09

Bid / Ask-- / --

YTD % change+17.54%

Volume2,493,568

Average volume (10-day)5,586,815

Average volume (1-month)4,778,060

Average volume (3-month)4,192,755

52-week range(U.S.) $34.06 to (U.S.) $50.16

Beta0.82

Trailing P/E5.04×

P/E 1 year forward23.10×

Forward PEG1.67×

Indicated annual dividend(U.S.) $0.52

Dividend yield1.16%

Trailing EPS(U.S.) $8.89

Updated December 9 4:01 PM EST. Delayed by at least 15 minutes.

Key company metrics

Open(U.S.) $44.21

Previous close(U.S.) $44.08

High(U.S.) $44.87

Low(U.S.) $44.09

Bid / Ask-- / --

YTD % change+17.54%

Volume2,493,568

Average volume (10-day)5,586,815

Average volume (1-month)4,778,060

Average volume (3-month)4,192,755

52-week range(U.S.) $34.06 to (U.S.) $50.16

Beta0.82

Trailing P/E5.04×

P/E 1 year forward23.10×

Forward PEG1.67×

Indicated annual dividend(U.S.) $0.52

Dividend yield1.16%

Trailing EPS(U.S.) $8.89

Updated December 9 4:01 PM EST. Delayed by at least 15 minutes.

About

Baxter International Inc., through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous

Restrictions

All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. ‘Thomson Reuters’ and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.